Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Early Hum Dev. 2016 Aug 22;103:97–100. doi: 10.1016/j.earlhumdev.2016.08.003

Table 1.

Demographics.

G-tube (n = 25) No G-tube (n = 60) P-value
Category 1: non-modifiable risk factors
Birth weight ≥ 2500 g 80% 93% 0.08
Gestational age ≥ 36 weeks 88% 93% 0.41
Prenatal diagnosis 72% 47% 0.06
Female 40% 28% 0.32
Hispanic ethnicity 20% 23% >0.99
Apgar at 5 min ≥ 5 84% 83% 0.15
Chromosomal anomaly 4% 5% 0.79
Congenital heart disease 28% 28% >0.99
Category 2: modifiable risk factors within first week
ECMO 48% 3% <0.001
Epinephrine 76% 42% 0.01
Nitric oxide 84% 40% <0.001
Repair by 1 week 24% 72% <0.001
Category 3: modifiable risk factors after first week
Proton pump inhibitor 68% 10% <0.001
H2 receptor antagonist 76% 37% 0.002
Sildenafil 24% 2% 0.002
Dexmedetomidine 28% 5% 0.01
Any maternal breast milk 36% 65% 0.02

ECMO: extracorporeal membrane oxygenation; G-tube: gastrostomy tube.